MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jrr/rraa025

Медицинская библиотека · Journal of radiation research · 2020

Preliminary survey of 3D image-guided brachytherapy for cervical cancer at representative hospitals in Asian countries.

Okonogi Noriyuki, Wakatsuki Masaru, Mizuno Hideyuki, Fukuda Shigekazu, Cao Jianping, Kodrat Henry, Lau Fen Nee, Calaguas Miriam Joy, de Los Reyes Rey H, Chansilpa Yaowalak, Uddin A F M Kamal, Adylkhanov Tasbolat, Cho Chul-Koo, Tsegmed Uranchimeg, Hoang Nguyen Cong, Ohno Tatsuya, Nakano Takashi, Kato Shingo, Forum for Nuclear Cooperation in Asia

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

3D image-guided brachytherapy (3D-IGBT) has become a standard therapy for cervical cancer. However, the use of 3D-IGBT is limited in East and Southeast Asia. This study aimed to clarify the current usage patterns of 3D-IGBT for cervical cancer in East and Southeast Asia. A questionnaire-based survey was performed in 11 countries within the framework of the Forum for Nuclear Cooperation in Asia. The questionnaire collected the treatment information of patients with cervical cancer who underwent 3D-IGBT. The cumulative external beam radiotherapy and 3D-IGBT doses were summarized and normalized to a biological equivalent dose of 2 Gy per fraction (EQD2) using a linear-quadratic model. Of the 11 institutions representing the participating countries, six (55%) responded to the questionnaire. Overall, data of 36 patients were collected from the six institutions. Twenty-one patients underwent whole-pelvic irradiation and 15 underwent whole-pelvic irradiation with central shielding. Patients received a median of four treatment sessions of 3D-IGBT (range, 2-6). All 3D-IGBT sessions were computed tomography (CT)-based and not magnetic resonance image-based. The median doses to the high-risk clinical target volume D90, bladder D2cc, rectum D2cc and sigmoid colon D2cc were 80.9 Gy EQD2 (range, 58.9-105.9), 77.7 Gy EQD2 (range, 56.9-99.1), 68.0 Gy EQD2 (range, 48.6-90.7) and 62.0 Gy EQD2 (range, 39.6-83.7), respectively. This study elucidated the current patterns of 3D-IGBT for the treatment of cervical cancer in East and Southeast Asia. The results indicate the feasibility of observational studies of CT-based 3D-IGBT for cervical cancer in these countries.

Для цитирования: Okonogi Noriyuki, Wakatsuki Masaru, Mizuno Hideyuki, Fukuda Shigekazu, Cao Jianping, Kodrat Henry, Lau Fen Nee, Calaguas Miriam Joy, de Los Reyes Rey H, Chansilpa Yaowalak, Uddin A F M Kamal, Adylkhanov Tasbolat, Cho Chul-Koo, Tsegmed Uranchimeg, Hoang Nguyen Cong, Ohno Tatsuya, Nakano Takashi, Kato Shingo, Forum for Nuclear Cooperation in Asia. Preliminary survey of 3D image-guided brachytherapy for cervical cancer at representative hospitals in Asian countries.. Journal of radiation research. 2020. DOI: 10.1093/jrr/rraa025.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.